Page last updated: 2024-10-16

4-hydroxybenzoic acid and Amyotrophic Lateral Sclerosis

4-hydroxybenzoic acid has been researched along with Amyotrophic Lateral Sclerosis in 1 studies

4-hydroxybenzoic acid : A monohydroxybenzoic acid that is benzoic acid carrying a hydroxy substituent at C-4 of the benzene ring.

Amyotrophic Lateral Sclerosis: A degenerative disorder affecting upper MOTOR NEURONS in the brain and lower motor neurons in the brain stem and SPINAL CORD. Disease onset is usually after the age of 50 and the process is usually fatal within 3 to 6 years. Clinical manifestations include progressive weakness, atrophy, FASCICULATION, hyperreflexia, DYSARTHRIA, dysphagia, and eventual paralysis of respiratory function. Pathologic features include the replacement of motor neurons with fibrous ASTROCYTES and atrophy of anterior SPINAL NERVE ROOTS and corticospinal tracts. (From Adams et al., Principles of Neurology, 6th ed, pp1089-94)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bogdanov, MB1
Ramos, LE1
Xu, Z1
Beal, MF1

Other Studies

1 other study available for 4-hydroxybenzoic acid and Amyotrophic Lateral Sclerosis

ArticleYear
Elevated "hydroxyl radical" generation in vivo in an animal model of amyotrophic lateral sclerosis.
    Journal of neurochemistry, 1998, Volume: 71, Issue:3

    Topics: Amyotrophic Lateral Sclerosis; Animals; Corpus Striatum; Humans; Hydroxybenzoates; Hydroxyl Radical;

1998